Research map: Impact of dosing interval on immunogenicity following a heterologous typhoid conjugate vaccine booster in Nepalese children: an observational study

Back to the article

Papers in this map

  1. MatchIt : Nonparametric Preprocessing for Parametric Causal Inference · Daniel E. Ho · 2011 · 4495 citations · Cited by this paper
  2. A randomised comparison of management strategies for drug-induced liver injury associated with tuberculous meningitis treatment · 2026 · Related
  3. Safety and Immunogenicity of a Vi Polysaccharide–Tetanus Toxoid Conjugate Vaccine (Typbar-TCV) in Healthy Infants, Children, and Adults in Typhoid Endemic Areas: A Multicenter, 2-Cohort, Open-Label, Double-Blind, Randomized Controlled Phase 3 Study · Vadrevu Krishna Mohan · 2015 · 208 citations · Cited by this paper
  4. Global surveillance reveals progressive erosion of benzylpenicillin susceptibility in Streptococcus suis · 2026 · Related
  5. Protection by vaccination of children against typhoid fever with a Vi-tetanus toxoid conjugate vaccine in urban Bangladesh: a cluster-randomised trial · Firdausi Qadri · 2021 · 162 citations · Cited by this paper
  6. Home-based rapid testing and early antiviral treatment as a potential strategy to blunt pediatric influenza peak · 2026 · Related
  7. Safety and Efficacy of a Typhoid Conjugate Vaccine in Malawian Children · Priyanka D Patel · 2021 · 149 citations · Cited by this paper
  8. Remdesivir triphosphate as a potential repurposed drug against the emerging Bundibugyo Ebolavirus 2026 · 2026 · Related
  9. Efficacy of typhoid conjugate vaccine in Nepal: final results of a phase 3, randomised, controlled trial · Mila Shakya · 2021 · 109 citations · Cited by this paper
  10. Metagenomic sequencing as a diagnostic tool for urine culture negative febrile urinary tract infection · 2026 · Related
  11. Burden of enteric fever at three urban sites in Africa and Asia: a multicentre population-based study · James Meiring · 2021 · 106 citations · Cited by this paper
  12. Global disability-adjusted life years burden of lower respiratory infections caused by Streptococcus pneumoniae, Staphylococcus aureus, and Klebsiella pneumoniae, 1990–2021: A systematic analysis of the global burden of disease study 2021 · 2026 · Related
  13. The global burden of enteric fever, 2017–2021: a systematic analysis from the global burden of disease study 2021 · Daniele Piovani · 2024 · 74 citations · Cited by this paper
  14. Long-term immunogenicity and safety of RZV primary vaccination and revaccination in kidney transplant recipients · 2026 · Related
  15. 5-year vaccine protection following a single dose of Vi-tetanus toxoid conjugate vaccine in Bangladeshi children (TyVOID): a cluster randomised trial · Firdausi Qadri · 2024 · 41 citations · Cited by this paper
  16. Serological outcomes of SARS-CoV-2 infection by vaccination status and variant in England · 2026 · Related
  17. A multicenter, single-blind, randomized, phase-2/3 study to evaluate immunogenicity and safety of a single intramuscular dose of biological E’s Vi-capsular polysaccharide-CRM 197 conjugate typhoid vaccine (TyphiBEV TM ) in healthy infants, children, and adults in comparison with a licensed comparator · Subhash Thuluva · 2022 · 35 citations · Cited by this paper
  18. Determinants of fatalities and secondary transmission in laboratory pathogen incidents, 1900–2025 · 2026 · Related
  19. Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine · Bernie Endyarni Medise · 2019 · 27 citations · Cited by this paper
  20. Within-host evolution of tandemly duplicated blaKPC-14 conferring cross-resistance to ceftazidime-avibactam, cefiderocol and aztreonam-avibactam in hypervirulent ST11 Klebsiella pneumoniae · 2026 · Related
  21. Immune persistence and response to booster dose of Vi-DT vaccine at 27.5 months post-first dose · María Rosario Capeding · 2022 · 12 citations · Cited by this paper
  22. Immune responses to typhoid conjugate vaccine in a two dose schedule among Nepalese children <2 years of age · Sanjeev Man Bijukchhe · 2024 · 9 citations · Cited by this paper
  23. Real-world vaccine effectiveness of typhoid conjugate vaccine in children and adolescents: a systematic review and meta-analysis · Jonathan Hasian Haposan · 2025 · 7 citations · Cited by this paper
  24. Immunogenicity and reactogenicity of a booster dose of a typhoid conjugate vaccine (TCV) in Malawian pre-school children · Nginache Nampota-Nkomba · 2025 · 6 citations · Cited by this paper
  25. Single and two-dose typhoid conjugate vaccine safety and immunogenicity in HIV-exposed uninfected and HIV-unexposed uninfected Malawian children · Nginache Nampota-Nkomba · 2024 · 3 citations · Cited by this paper

Source: OpenAlex (CC0)